8400 The Health Network

8400 The Health Network Overview

8400 was founded in 2017 on the premise that HealthTech is Israel’s next economic growth engine and Israel has what it takes to become a game-changing player in the global HealthTech revolution. A culture of innovation and multidisciplinary talent has driven Israel’s global high-tech success story. Add to this the unique assets of a digital healthcare infrastructure within a nationally orchestrated healthcare system, and Israel’s HealthTech edge becomes a no-brainer. With a purposeful focus on diversity and inclusion as pre-conditions for growth, 8400 has pioneered a powerful network of Israeli leaders across all HealthTech functions, which is globally connected and shares a common language across the public and private sectors. Through strategic ecosystem collaborations and national programs that also engage diverse leaders from the geographic and demographic periphery, 8400 amplifies Israel’s assets to drive a HealthTech economic growth engine and accelerate cures.

Latest News

Jun 30, 2025 · www.globes.co.il

growth-positive

השקעה של עשרות מיליוני דולרים: תוכנית החדשנות שמשיקה טבע

Teva, a pharmaceutical giant, has launched an innovation program aimed at startups, with an investment expected to reach tens of millions of dollars. The program will introduce challenges twice a year, focusing on integrating innovation across Tevas operations, from drug discovery to logistics and marketing. Selected startups will begin pilot projects with full funding from Teva. The initiative is international but launched in Israel, in collaboration with the Israel Innovation Authority, 8400 Network, IATI, and Start-Up Nation Central. Teva aims to leverage AI technology and strengthen its ties with the Israeli biomedical ecosystem. The program aligns with Tevas Pivot to Growth strategy, emphasizing innovative products and rapid growth.

Product StagePartnersInvestment

Jun 30, 2025 · www.ynet.co.il

growth-positive

הכיוון החדש של טבע: תשקיע עשרות מיליונים בחברות ביופארמה ישראליות

Teva Pharmaceutical Industries is shifting its focus towards innovative biopharmaceuticals, investing tens of millions of dollars annually in Israeli biopharma companies. This move is part of Tevas Pivot to Growth strategy, aiming to increase its self-developed drug segment at the expense of generic drugs. The company plans to lay off 3,000 employees globally, including around 300 in Israel, to reallocate resources towards research and development. Teva has also raised $2 billion in bonds to support its R&D efforts. The company is leveraging Israels innovation ecosystem, collaborating with local universities, hospitals, and startups. Tevas global innovation program was launched in Israel, emphasizing its commitment to integrating innovation across all business units.

InvestmentLayoffsPartners

Sep 17, 2019 · www.globes.co.il

"מועדון העילית" של תעשיית הבריאות מציג 3 פרויקטים חדשים

Nov 27, 2018 · www.jns.org

growth-positive

From innovation nation to impact nation

Cellect Biotechnology, founded by Nuriel Chirich Kasbian and Dr. Shai Yarkoni, has developed a technology called ApoGraft that allows for the mass enrichment of stem cells and more effective isolation of stem cells from any given tissue. The technology has the potential to improve the effectiveness of regenerative treatments for various diseases. Cellect has conducted over 200 human trials with a 100% success rate and is collaborating with Harvard University, Stanford University, and Washington University in St. Louis medical schools on clinical trials. The company aims to make stem cell treatments more accessible, affordable, and non-toxic. The article also mentions the establishment of a new Israeli health network called 8400, which aims to transform the health-tech ecosystem into a growth engine for Israel and accelerate cures for international health challenges. MedAware, another Israeli company, is using AI and machine learning to reduce medication errors in healthcare.

PartnersExpand

Oct 23, 2018 · en.globes.co.il

growth-positive

Exclusive program launched for medical industry leaders

8400 - The Health Network is a leadership training and development program for executives in the medical industry. The program aims to turn medical industry company leaders into ecosystem leaders. The project has already attracted participation from leading executives in the industry. The project is supported by aMoon Fund, Isaac Devash, Israel Biotech Fund, Teva Pharmaceutical Industries Ltd., Sol Barer, Sami Sagol, and Nir Kalkstein. The program involves 20 days of lectures, group work, and a weeklong event sponsored by the Harvard Business School. The project focuses on cross-sector collaboration, identifying bottlenecks in the industry, and finding ways to turn the health sector into a growth engine. The project also includes initiatives related to regulation, intellectual property, mentoring, and the use of medical information. The goal is to have 400 participants over eight years.

PartnersInvestment

Team Members

11

Web & Social Links

Locations

Rokach Blvd 97, Tel Aviv-Yafo, 6902064, Israel

Photos & Videos

8 item(s)

8400 The Health Network Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info